CLE CCC Warm Light
NDC 69231-023, Titanium Dioxide, Octinoxate, Octisalate, cream, from KW ABSC, INC..
- Product NDC
- 69231-023
- Status
- Listed
- Labeler
- KW ABSC, INC.
- Dosage form
- CREAM
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH NOT FINAL
- Application
- part352
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69231-023 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OCTINOXATE2.1 mg/30mL
- OCTISALATE.9 mg/30mL
- TITANIUM DIOXIDE2.6376 mg/30mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69231-023-02 | 69231002302 | 1 CONTAINER in 1 PACKAGE (69231-023-02) / 30 mL in 1 CONTAINER (69231-023-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 69231-023 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69231-023 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69231-023. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.